Astec Lifesciences Q1 Results Live : loss rise by 384.77% YOY
Astec Lifesciences Q1 Results Live : Revenue decreased by 51.44% YoY & loss increased by 384.77% YoY
Astec Lifesciences Q1 Results Live : Astec Lifesciences announced their Q1 results on 29 Jul, 2024, revealing a significant decrease in revenue and a substantial increase in losses compared to the same period last year.
The company's topline decreased by 51.44% YoY, while the loss surged by 384.77% YoY. In comparison to the previous quarter, revenue declined by 54.88% and losses increased by a staggering 3978.92%.
Selling, general & administrative expenses saw a rise of 10.52% q-o-q and 5.53% Y-o-Y. Operating income took a hit, down by 1599.82% q-o-q and 787.87% Y-o-Y.
The earnings per share (EPS) for Q1 stood at ₹-20.26, marking a decrease of 384.69% Y-o-Y.
In terms of returns, Astec Lifesciences delivered -0.35% in the last week, 24.74% in the last 6 months, and 12.6% YTD.
As of now, Astec Lifesciences commands a market capitalization of ₹2418.44 Cr with a 52-week high/low of ₹1490 and ₹825.05 respectively.
Astec Lifesciences Financials
| Period | Q1 | Q4 | Q-o-Q Growth | Q1 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 69.37 | 153.75 | -54.88% | 142.85 | -51.44% |
| Selling/ General/ Admin Expenses Total | 16.23 | 14.69 | +10.52% | 15.38 | +5.53% |
| Depreciation/ Amortization | 9.27 | 9.01 | +2.87% | 9.39 | -1.28% |
| Total Operating Expense | 124.89 | 150.05 | -16.76% | 149.1 | -16.24% |
| Operating Income | -55.52 | 3.7 | -1599.82% | -6.25 | -787.87% |
| Net Income Before Taxes | -61.64 | -0.93 | -6556.52% | -11.01 | -460.01% |
| Net Income | -39.72 | -0.97 | -3978.92% | -8.19 | -384.77% |
| Diluted Normalized EPS | -20.26 | -0.5 | -3952% | -4.18 | -384.69% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.